A Review on Ophthalmologic Manifestations in Beta-Thalassemia Major Patients
Journal of Ophthalmic and Optometric Sciences,
Vol. 6 No. 2 (2022),
8 November 2023
,
Page 37-51
https://doi.org/10.22037/joos.v6i2.42366
Abstract
Background: Beta-thalassemia is an inherited blood disorder that leads to early apoptosis of red blood cells (RBCs), ineffective erythropoiesis, and ocular complications. The disease is classified into beta-thalassemia minor (β-TMi), beta-thalassemia intermedia (β-TI), and beta-thalassemia major (β-TM).We aim to review various functional and structural ocular manifestations of β-TM patients in different studies and present the most important findings based on the prevalence and etiologies of each ocular complication.
Materials and methods: To reach this purpose, we developed a search strategy using the keywords “eye disease,” “ocular complications,” “ocular manifestations,” and “ocular abnormality,” each with “beta-thalassemia” in the two popular search engines PubMed and Google Scholar up to December 2022. We also reviewed related references of the chosen papers.
Results: According to the literature review, the most consistent is the correlation of β-TM with dry eye disease and fundus alterations, while there are still many challenges regarding the prevalence and etiologies of other ocular complications in β-TM patients.
Conclusion: This finding warrants studies with larger sample sizes to reach more reliable results and take them into action for preventing and timely diagnosing such ocular complications.
- Beta-Thalassemia Major
- Ocular Complications
- Iron Chelation Therapy
- Iron Overload
- 2022-04-03 (2)
- 2023-11-14 (1)
How to Cite
References
Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bulletin of the World Health Organization. 2008;86(6):480-7.
Cao A, Galanello R. Beta-thalassemia. Genetics in medicine. 2010;12(2):61-76.
Rachmilewitz EA, Giardina PJ. How I treat thalassemia. Blood, The Journal of the American Society of Hematology. 2011;118(13):3479-88.
Kattamis A, Forni GL, Aydinok Y, Viprakasit V. Changing patterns in the epidemiology of β‐thalassemia. European Journal of Haematology. 2020;105(6):692-703.
Weatherall DJ, Clegg JB. The thalassaemia syndromes: John Wiley & Sons; 2008.
Galanello R, Origa R. Beta-thalassemia. Orphanet journal of rare diseases. 2010;5:1-15.
Daar S, Pathare A. Combined therapy with desferrioxamine and deferiprone in beta thalassemia major patients with transfusional iron overload. Annals of hematology. 2006;85:315-9.
Rund D. Rachmilewitz E. b-thalassemia. N Engl J Med. 2005;353(11):1135-46.
Liaska A, Petrou P, Georgakopoulos CD, Diamanti R, Papaconstantinou D, Kanakis MG, et al. β-Thalassemia and ocular implications: a systematic review. BMC ophthalmology. 2016;16(1):1-13.
Borgna-Pignatti C, Marsella M. Iron chelation in thalassemia major. Clinical therapeutics. 2015;37(12):2866-77.
Elkitkat RS, El-Shazly AA, Ebeid WM, Deghedy MR. Relation of anthropometric measurements to ocular biometric changes and refractive error in children with thalassemia. European Journal of Ophthalmology. 2018;28(2):139-43.
Heydarian S, Jafari R, Karami H. Refractive errors and ocular biometry components in thalassemia major patients. International ophthalmology. 2016;36:267-71.
Merchant RH, Punde H, Thacker N, Bhatt D. Ophthalmic evaluation in beta-thalassemia. The Indian Journal of Pediatrics. 2017;84:509-14.
Abo-Zied SS, Elgemaey HM, Abd-Aal HM. Impact of new chelating agents on ocular abnormalities in β-thalassemia major patients: a comparative study. Alexandria Journal of Pediatrics. 2021;34(2):136-43.
Jafari R, Heydarian S, Karami H, Shektaei MM, Dailami KN, Amiri AA, et al. Ocular abnormalities in multi-transfused beta-thalassemia patients. Indian Journal of Ophthalmology. 2015;63(9):710.
Nuzzi R, Geronazzo G, Tridico F, Nuzzi A, Caselgrandi P, Piga AG. Long-term effects of Iron chelating agents on ocular function in patients with thalassemia major. Clinical Ophthalmology. 2021:2099-109.
Ramakrishnan R, Agrawal M, Gandhi P, Choudhary A, Jesmin A, Choudhary A. A study of the spectrum of ocular manifestations in patients with thalassemia. MGM Journal of Medical Sciences. 2021;8(2):120-3.
Thakur R, Goel M. Ocular Manifestations in Multi-Transfused Beta-Thalassemia Patients.
Haghpanah S, Zekavat OR, Bordbar M, Karimi M, Zareifar S, Safaei S, et al. Ocular findings in patients with transfusion-dependent β-thalassemia in southern Iran. BMC ophthalmology. 2020;20:1-7.
Ebeid WM, Kenny MA, Badran TA. Evaluation of Corneal Epithelial Thickness and Dry Eye Disease Tests in Thalassemic Adolescents. Clinical Ophthalmology. 2021:1425-31.
Fagehi R, Abbadi IM, Abusharha A, Alanazi MA, Malhan H, El-Hiti GA, et al. Evaluation of the Significance of Tear Ferning Patterns in beta-Thalassemia Patients. Klinische Monatsblätter für Augenheilkunde. 2022;239(06):804-11.
Mehdizadeh M, Nowroozzadeh MH. Posterior subcapsular opacity in two patients with thalassaemia major following deferiprone consumption. Clinical and Experimental Optometry. 2009;92(4):392-4.
Pascolini D, Mariotti SP. Global estimates of visual impairment: 2010. British Journal of Ophthalmology. 2012;96(5):614-8.
Chylack LT, Leske MC, Sperduto R, Khu P, McCarthy D. Lens opacities classification system. Archives of Ophthalmology. 1988;106(3):330-4.
Pratap T, Kokil P. Computer-aided diagnosis of cataract using deep transfer learning. Biomedical Signal Processing and Control. 2019;53:101533.
Taneja R, Malik P, Sharma M, Agarwal MC. Multiple transfused thalassemia major: ocular manifestations in a hospital-based population. Indian journal of ophthalmology. 2010;58(2):125.
Akritidou F, Praidou A, Papamitsou T, Kozobolis V, Labiris G. Ocular manifestations in patients with transfusion-dependent β-thalassemia. Hippokratia. 2021;25(2):79.
Bhoiwala DL, Dunaief JL. Retinal abnormalities in β-thalassemia major. Survey of ophthalmology. 2016;61(1):33-50.
Błasiak J, Skłodowska A, Ulińska M, Szaflik JP. Iron and age-related macular degeneration. Klinika Oczna/Acta Ophthalmologica Polonica. 2009;111(2):174-7.
Saif AT, Saif PS, Dabous O. Fundus changes in thalassemia in Egyptian patients. Delta Journal of Ophthalmology. 2017;18(1):20-5.
Jethani J, Marwah K, Patel S, Shah B. Ocular abnormalities in patients with beta thalassemia on transfusion and chelation therapy: our experience. Indian Journal of Ophthalmology. 2010;58(5):451-2.
Simon S, Athanasiov PA, Jain R, Raymond G, Gilhotra JS. Desferrioxamine-related ocular toxicity: a case report. Indian journal of ophthalmology. 2012;60(4):315.
Wu C-H, Yang C-P, Lai C-C, Wu W-C, Chen Y-H. Deferoxamine retinopathy: spectral domain-optical coherence tomography findings. BMC ophthalmology. 2014;14:1-3.
Vahdani K, Makrygiannis G, Kaneshyogan H, Sian IS, Giasin O. Bilateral central serous retinopathy in a patient with paroxysmal nocturnal hemoglobinuria treated with deferoxamine. European Journal of Ophthalmology. 2016;26(6):e152-e4.
Gelman R, Kiss S, Tsang SH. Multimodal imaging in a case of deferoxamine induced maculopathy. Retinal cases & brief reports. 2014;8(4):306.
Genead MA, Fishman GA, Anastasakis A, Lindeman M. Macular vitelliform lesion in desferrioxamine-related retinopathy. Documenta ophthalmologica. 2010;121:161-6.
Chen S-H, Liang D-C, Lin H-C, Cheng S-Y, Chen L-J, Liu H-C. Auditory and visual toxicity during deferoxamine therapy in transfusion-dependent patients. Journal of Pediatric Hematology/Oncology. 2005;27(12):651-3.
Aksoy A, Aslan L, Aslankurt M, Eser O, Garipardic M, Okumus S, et al., editors. Retinal fiber layer thickness in children with thalessemia major and iron deficiency anemia. Seminars in Ophthalmology; 2014: Taylor & Francis.
Ulusoy MO, Türk H, Kıvanç SA. Spectral domain optical coherence tomography findings in Turkish sickle-cell disease and beta thalassemia major patients. Journal of Current Ophthalmology. 2019;31(3):275-80.
Uzun F, Karaca EE, Yerlikaya GY, Fındık H, Akın M. Retinal nerve fiber layer thickness in children with β-thalassemia major. Saudi journal of ophthalmology. 2017;31(4):224-8.
Haghpanah S, Zekavat OR, Safaei S, Ashraf MA, Parand S, Ashraf H. Optical coherence tomography findings in patients with transfusion-dependent β-thalassemia. BMC ophthalmology. 2022;22(1):1-9.
Johnson CA, Wall M, Thompson HS. A history of perimetry and visual field testing. Optometry and Vision Science. 2011;88(1):E8-E15.
Shahriari H, Ghasemzadeh F, Eshghi P, Masoomian B. Ocular side effects of desferal in patients with β thalassemia. Bina J Ophthalmol. 2006;11:519-23.
Marsden J, Stevens S, Ebri A. How to measure distance visual acuity. Community eye health. 2014;27(85):16.
Hamilton R, Bach M, Heinrich SP, Hoffmann MB, Odom JV, McCulloch DL, et al. VEP estimation of visual acuity: a systematic review. Documenta Ophthalmologica. 2021;142:25-74.
- Abstract Viewed: 90 times
- pdf Downloaded: 47 times
